ALXN: Alexion Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 23,458.63
Enterprise Value ($M) 24,892.60
Book Value ($M) 9,706.60
Book Value / Share 43.29
Price / Book 2.42
NCAV ($M) -642.40
NCAV / Share -2.86
Price / NCAV -36.52

Profitability (mra)
Return on Invested Capital (ROIC) 0.01
Return on Assets (ROA) 0.01
Return on Equity (ROE) 0.01

Liquidity (mrq)
Quick Ratio 3.36
Current Ratio 3.87

Balance Sheet (mrq) ($M)
Current Assets 3,650.60
Assets 13,999.60
Liabilities 4,293.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 269.60
Net Income 77.60
Earnings Per Share Basic 0.35
Earnings Per Share Diluted 0.35

Cash Flow Statement (mra) ($M)
Cash From Operations 426.00
Cash from Investing 470.50
Cash from Financing 470.50

Source:
Fintel.io

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2019-02-14 13G/A Price T Rowe Associates Inc /md/ 7.90 -21.29
2019-02-13 13G/A FMR LLC / Fidelity 11.88 6.84
2019-02-12 13G/A State Street Corp 4.90 -4.97
2019-02-11 13G/A Vanguard Group Inc 7.27 6.70
2019-02-04 13G/A BlackRock Inc. 7.30 -9.85
2017-02-13 13G/A Capital Research Global Investors 3.20 -52.36

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

Source:
Fintel.io

Date Insider Trades Code Shares Value

Source:
Fintel.io

File Date Form SEC Filings
2019-07-24 10-Q ALXN / Alexion Pharmaceuticals, Inc. 10-Q – Quarterly Report – 10-Q
2019-04-25 10-Q ALXN / Alexion Pharmaceuticals, Inc. 10-Q (Quarterly Report) 10-Q
2019-02-06 10-K ALXN / Alexion Pharmaceuticals, Inc. FORM 10-K (Annual Report)
2018-10-24 10-Q ALXN / Alexion Pharmaceuticals, Inc. 10-Q (Quarterly Report)

Source:
Fintel.io

Similar Companies
ALPN – Alpine Immune Sciences Inc ALT – Altimmune, Inc.
ALXA – Alexza Pharmaceuticals, Inc. AMAG – AMAG Pharmaceuticals, Inc.
AMBI – Ambit Biosciences Corp


Financial data and stock pages provided for FREE by
Fintel.io